Table 1. Randomised controlled trials included in the systematic review and network meta-analysis.
Study | Trials | Clinical trial cycle (months) | data cutoff | Trial phase | No. of center | BRCA mutation type | HR | Stage of breast cancer | previous chemotherapy regimens for metastatic disease | previous cytotoxic regimens for advanced breast cancer |
Robson et al.2017 | OlympiAD | 15 | Dec.9, 2016 | III | 18 | BRCA1/BRCA2/both | positive/negative | metastatic breast cancer | no more than two | unknown |
Litton et al.2018 | EMBRACA | 42 | Sep.15, 2017 | III | 16 | BRCA1/BRCA2 | positive/negative | metastatic or local advanced breast cancer | unknown | no more than three |